The drugs with elamipretide as the leading raw content have entered the 3rd phase of clinical exercise.Elamipretide triacetate is definitely an aromatic-cationic tetrapeptide that targets the mitochondrial intima which is an inhibitor of cardiolipin peroxidase. It effortlessly penetrates mobile membranes and has been used in therapeutic trials inve